Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Emmerling

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|July 19, 1996
Identification of a 3-hydroxylated tacrine metabolite in rat and man: metabolic profiling implications and pharmacologyW F Pool, T F Woolf, M D Reily, et al.
Journal of Electron Microscopy Technique|June 1, 1990
Biochemical and morphological differentiation of acetylcholinesterase-positive efferent fibers in the mouse cochleaM R Emmerling, H M Sobkowicz, C V Levenick, et al.
Annals of the New York Academy of Sciences|January 17, 1996
The role of arachidonic acid in the secretion of the amyloid precursor protein (APP)M R Emmerling, D T Dudley, R D Dyer, et al.
Journal of Neuropathology and Experimental Neurology|April 12, 2000
The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer diseaseT G Beach, Y M Kuo, K Spiegel, et al.
Molecular Medicine (Cambridge, Mass.)|August 22, 2000
Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's diseaseY M Kuo, F Crawford, M Mullan, et al.
Brain Research|April 3, 1995
Secretion and accumulation of Alzheimer's beta-protein by cultured vascular smooth muscle cells from old and young dogsJ Frackowiak, B Mazur-Kolecka, H M Wisniewski, et al.
Biochemical and Biophysical Research Communications|December 5, 1998
Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levelsY M Kuo, M R Emmerling, C L Bisgaier, et al.
Journal of Neurochemistry|April 27, 1999
Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reductionM D Kane, R D Schwarz, L St Pierre, et al.
FEBS Letters|November 14, 1994
Interleukin-1 beta dissociates beta-amyloid precursor protein and beta-amyloid peptide secretionJ P Vasilakos, R T Carroll, M R Emmerling, et al.
Journal of Neuropathology and Experimental Neurology|April 10, 1999
Apolipoprotein E alters metabolism of AbetaPP in cells engaged in beta-amyloidosisB Mazur-Kolecka, J Frackowiak, J Krzeslowska, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|July 19, 1996
Identification of a 3-hydroxylated tacrine metabolite in rat and man: metabolic profiling implications and pharmacologyW F Pool, T F Woolf, M D Reily, et al.
Journal of Electron Microscopy Technique|June 1, 1990
Biochemical and morphological differentiation of acetylcholinesterase-positive efferent fibers in the mouse cochleaM R Emmerling, H M Sobkowicz, C V Levenick, et al.
Annals of the New York Academy of Sciences|January 17, 1996
The role of arachidonic acid in the secretion of the amyloid precursor protein (APP)M R Emmerling, D T Dudley, R D Dyer, et al.
Journal of Neuropathology and Experimental Neurology|April 12, 2000
The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer diseaseT G Beach, Y M Kuo, K Spiegel, et al.
Molecular Medicine (Cambridge, Mass.)|August 22, 2000
Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's diseaseY M Kuo, F Crawford, M Mullan, et al.
Brain Research|April 3, 1995
Secretion and accumulation of Alzheimer's beta-protein by cultured vascular smooth muscle cells from old and young dogsJ Frackowiak, B Mazur-Kolecka, H M Wisniewski, et al.
Biochemical and Biophysical Research Communications|December 5, 1998
Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levelsY M Kuo, M R Emmerling, C L Bisgaier, et al.
Journal of Neurochemistry|April 27, 1999
Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reductionM D Kane, R D Schwarz, L St Pierre, et al.
FEBS Letters|November 14, 1994
Interleukin-1 beta dissociates beta-amyloid precursor protein and beta-amyloid peptide secretionJ P Vasilakos, R T Carroll, M R Emmerling, et al.
Journal of Neuropathology and Experimental Neurology|April 10, 1999
Apolipoprotein E alters metabolism of AbetaPP in cells engaged in beta-amyloidosisB Mazur-Kolecka, J Frackowiak, J Krzeslowska, et al.
Pageof 5